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Regulatory and HTA documents were analyzed to identify the processes of appraisal, 
indications assessed and key factors driving agency decisions. Results: Overall, 
twenty-one indications were appraised for the four biosimilars collectively; 90% of 
appraisals produced a decision of ‘recommended’, 9% were ‘recommended with 
restrictions’, and 1% were ‘not recommended’. Demonstration of clinical compa-
rability between the biosimilar and the reference product was a requirement in 
all countries. Cost-minimization and budget impact analyses were key economic 
decision factors. Some agencies accepted the notion of comparability for extrapola-
tion to indications other than those that had been studied in clinical trials. Pricing 
dynamics were seen to differ between biosimilars, driven by a combination of pric-
ing strategies for reference biologics, and payer and physician reservations about 
potential risks. ConClusions: Regulatory bodies follow common principles of 
assessment but differences exist with respect to scope and choice of reference prod-
uct. Important factors common to reimbursement agencies included comparable 
efficacy and safety of biosimilars to the reference products, and economic consid-
erations; however, they differed in their appraisal processes. The relative weight of 
price versus potential risk may vary with the disease area targeted by the biologic. 
The currently approved biosimilars have been relatively simple biologics to re-create 
and therefore evaluate, but the experience gained should be built upon to address 
the challenges of assessing the increasingly complex biosimilars being developed.
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objeCtives: This paper empirically investigates the role of patient-physician 
communication on the likelihood of receiving appropriate care, and its effect on 
health care costs at hospital inpatient settings. Methods: The Healthcare Cost and 
Utilization Project (HCUP) 2008-2010 State Inpatient Databases (SID) for Florida were 
used in this analysis. Then, we linked Florida SID with Florida Physician Licensure, 
the American Hospital Association Annual Survey Database; and the Area Resource 
File. Our key covariate of interest is the association between Spanish speaking phy-
sicians and Hispanic patients with the total costs associated with that visit. We 
started with descriptive analysis. Next, we used logistic regression models to assess 
likelihood of choosing a Spanish speaking physician over other physicians. Next, 
we used generalized linear regression models to estimate and then compare the 
health care costs associated Hispanic patients with Spanish speaking physicians 
against others. We also used Oaxaca-Blinder (OB) Decomposition to compare the 
health care costs between and within Hispanic and non-Hispanic white patients 
across Spanish and non-Spanish speaking physicians. To assess the robustness of 
our baseline results, we conducted several empirical estimations and tested their 
significance. Results: Our risk adjusted estimates show that the odds ratios for 
Hispanic patients registered to Spanish speaking physicians is 3.8 compared to 
non-Hispanic white patients registered to Spanish speaking physicians. We found 
that hospital inpatient costs associated with Hispanic patients registered to Spanish 
speaking physicians is about $650 less relative to Hispanic patients registered to 
non-Spanish speaking physicians. Our risk-adjusted results also show that hospi-
tal inpatient costs associated with non-Hispanic white patients registered to non-
Spanish speaking physicians relative to the non-Hispanic white patients registered 
to Spanish speaking physicians are lower by about $700 per visit. ConClusions: 
We found a strong correlation between Hispanic patients and Spanish speaking 
physicians. Better communications between patients and providers can provide 
patients with better care.
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objeCtives: The primary objective of this study is to examine the hospitals’ risk-
adjusted costs, and Medicare Advantage (MA) enrollees and Fee-for-service (FFS) 
beneficiaries’ use of high-cost hospitals. The second objective of this study is to 
document the variation in racial and ethnic disparity in visiting high-cost hospitals 
within and between MA enrollees and FFS beneficiaries as policymakers mostly have 
focused on the location of care as an explanation for important disparities in many 
health outcomes. Methods: We used 2006-2010 Healthcare Cost and Utilization 
Project State Inpatient Databases from California, Florida, Massachusetts, New York, 
Tennessee and Wisconsin; American Hospital Association Annual Survey Database; 
and Area Resource Files. We calculated the hospital cost index by dividing the actual 
total costs by casemix adjusted total costs. Next, we calculated three categorical 
values to define the dependent variable for each state, which takes value 1 if the 
hospital cost-index is less than 0.95; value 2 if it is within 0.95 -1.05; and, value 3 if it 
is greater than 1.05. We used ordered logistic regression models. We also estimated 
the same model using a different specification of high-cost hospital definitions to 
ascertain any effects resulting from sample sizes. Results: We found lower preva-
lence of high-cost hospitals among MA enrollees than among FFS beneficiaries. Our 
risk adjusted results show that the odds ratios of visiting a high-cost hospital for MA 
enrollees range from 0.641 to 0.958 for all states. Our results show that non-white 
elderly patients associated with lower likelihood of visiting high-cost hospitals in 
in California and New York, and higher likelihood of visiting high-cost hospitals in 
Florida, Massachusetts, Tennessee and Wisconsin. ConClusions: MA enrollees 
mostly utilize low-cost hospitals for their health care needs. We find sizable geo-
graphic variation in visiting high-cost hospitals among minority elderly population.
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life insurances, ranking #1 worldwide in 2012. For individuals who purchase private 
insurances to add protections it is natural to ask which insurance policy provides the 
most favorable return. The objective of this study is to establish a valuation system 
for private life and annuity insurance plans using a robust, flexible, distributed 
cloud computing architecture. Methods: Using the fixed income model and by 
constructing polynomial interpolated yield curves from Taiwan government and 
corporate bonds, we can approximate the internal rate of returns of each insur-
ance policy and compare their performance versus the time value of money of 
the total investments. We extracted daily information from over-the-counter mar-
kets and Taiwan interbank interest rates to compute daily changes in policy val-
ues. Results: Shown in our experiments, by investing in insurance policies from 
30 to 85 years old, the policies provide -0.1% to -1.4% returns, which represents the 
total value of investments has diminished throughout the years. Even in the event 
of benefit claims (severe injury or death), the insurances provides -0.2% to 1.5% 
returns. For annuity insurances, early investments do not provide advantages, i.e., 
by investing at 30 and by 50 years old, the returns is approximately the same at 85 
years old. ConClusions: We establish a robust, flexible and efficient valuation 
system for private life and annuity insurance plans. Results show that even by 
purchasing private insurances, the extra protections provided is still inadequate to 
cover major emergency medical conditions.
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objeCtives: The objective of this study is to estimate the effects of the 
Massachusetts health care reform on the use of inpatient hospital services in 
Massachusetts. Methods: We used Healthcare Cost and Utilization Project State 
Inpatient Databases for the years 2004-2011 in 37 states including Massachusetts. 
We identified a control group of hospitals from other states for each year based on 
their characteristics that match the hospitals in Massachusetts. Hospital-specific 
utilization was summarized by calendar quarter, and difference-in-differences time 
series models were estimated based on the multi-year implementation of reform 
initiatives in Massachusetts. We identified a pre-reform period (Q1 2004-Q3 2006), 
during period (Q4 2006-Q2 2007), and two post-reform periods (Q3 2007-Q1 2009 and 
Q2 2009-Q4 2011). Dependent variables were the quarterly estimate for each hospital 
of the natural logarithm of total discharges, average length of stay, the coefficient of 
variation in length of stay, and cost per discharge. Independent variables included 
annual measures of the Herfindahl-Hirschman Index, county-level measures of popu-
lation, household income, unemployment rate, labor force participation rate and a 
dichotomous variable indicating if the hospital was in Massachusetts and the stage of 
policy implementation in the state. The regression models also controlled for the dif-
ferential effects of the dramatic changes that occurred across the country. Results: 
Our descriptive results indicate that the number of discharges grew more rapidly in 
Massachusetts than in the rest of the country. Our risk adjusted results show that 
the full implementation of the reform legislation led to 5.8% more discharges, 5.0% 
shorter lengths of stay, a 2.5% reduction in the variation in a hospital’s length of stay 
and no change in cost per discharge – all relative to control hospitals. ConClusions: 
Massachusetts health care reform had a modest impact on inpatient utilization and 
that impact became greater the longer the reform was in place.
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objeCtives: Cost effectiveness analyses are required by various Health Technology 
Assessment (HTA) agencies as part of the reimbursement submission. To gain an 
insight into the methods used, we analyzed the cost effectiveness studies for the 
top twenty highest selling drugs (~$90-100B worldwide sales). Methods: The Top 20 
drugs were selected based on their worldwide sales. For this analysis, we segmented 
these drugs into categories such as primary care, specialty, small molecules, bio-
logics, therapy areas, and availability of generic alternatives. We analyzed the cost 
effectiveness studies that were published in peer-reviewed journals. Searches were 
conducted using generic names of the drugs and the phrase “cost effectiveness” in 
an abstract of the published study. Results: Between 2008-2013, the number of 
published studies on “cost effectiveness” has increased by more than 35%. There 
is a large variability in CERs for same drugs for different indications, in some cases 
also varying by biomarkers. Primary care drugs had lower and less variable CERs 
than specialty drugs. Variations also exist in methodology used by different groups 
in modeling cost effectiveness, especially for time horizon and comparator. The 
majority of primary care drugs were modeled for a time horizon of 35-40 years or for 
a lifetime to demonstrate cost effectiveness. ConClusions: This analysis shows 
the range, variability, and methods used for calculation of ICER values for these 
high budget impact drugs and provides lessons for executives and policy makers.
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objeCtives: Biosimilars are biotherapeutic products that are similar in terms of 
quality, safety and efficacy to an already licensed reference biologic. There are strict 
guidelines in place for the regulatory approval of biosimilars. However, HTA agen-
cies differ in their approaches to appraisal of biosimilars. This study examined 
the factors influencing regulatory and reimbursement decisions for biosimilars in 
different countries. Methods: A qualitative documentary analysis was performed 
of the regulatory approval and reimbursement of four biosimilars in nine countries. 
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objeCtives: The impact of health economics and outcomes research (HEOR) evi-
dence on reimbursement decisions is known and explicit in many major markets, 
but in the U.S. skepticism regarding the impact of such evidence on payer decision-
making remains. Despite this, strategic and tactical support from HEOR units in 
pharmaceutical companies is believed to have a substantial impact on the success 
of a product, as evidenced by continued and increasing investment in HEOR. We 
sought to understand, from a pharmaceutical manufacturer’s perspective, how the 
decision to invest in HEOR is made and how such evidence is believed to influence 
reimbursement and market access in the U.S. Methods: We conducted two focus 
group sessions followed by an online stated choice survey with HEOR representa-
tives from various pharmaceutical companies. Focus group sessions were centered 
on the scope of work conducted by HEOR units and how investment decisions are 
made. We subsequently developed and administered a survey that presented the 
HEOR representatives with 20 target product profiles and asked respondents to rate 
the perceived value that HEOR evidence would have on reimbursement decisions 
for each product and to identify the types of HEOR evidence that would be most 
useful for payers. Results: We identified eight types of HEOR evidence that are 
used to inform reimbursement decisions. Seven product attributes, four market 
attributes, three data quality attributes, and seven exogenous factors were identified 
as factors in the decision to invest in HEOR. We report the most influential factors 
and trends in the types of evidence pursued. ConClusions: This more nuanced 
understanding of the drivers of private HEOR investment and perceived value to 
payers will assist companies in planning future investments. These hypotheses 
will be evaluated with payers to assess the sensitivity of their decisions to HEOR 
evidence under specific product and market scenarios.
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objeCtives: The primary care landscape is constantly changing to meet the 
increased demands placed on physicians and health care delivery systems world-
wide. A major objective of primary care reform is the creation of patient-centered 
medical homes (PCMH) to manage the needs of an aging population with chronic 
conditions and complex comorbidities. To be successful, this model requires physi-
cians, nurses and other staff members to redefine their roles in the primary care 
space and build a multi-professional culture through valuing the contributions 
of each team-member. Our objective was to examine the attitudes of nurses and 
general practitioners toward physician-nurse collaboration in PCMHs in the Tuscany 
region, Italy. Methods: The Jefferson Scale of Attitudes Toward Physician-Nurse 
Collaboration was web-administered to a total of 218 general practitioners and 46 
nurses in two PCMHs. The scale consists of four subscales that assess: a) shared 
education and teamwork; b) caring versus curing; c) nurses’ autonomy; d) physician 
dominance. The t-test was used to compare the total and subscale scores between 
nurses and general practitioners. Results: A total of 39 nurses and 83 general prac-
titioners completed the survey with an overall response rate of 46%. We found that 
nurses had an overall significantly higher attitude toward physician-nurse collabo-
ration than general practitioners (p< 0.001). This significant difference in attitudes 
was also seen in each subscale component of the Jefferson Scale. ConClusions: 
Nurses appeared to have a more positive attitude toward multiprofessional col-
laboration than general practitioners in PCMHs of the Tuscany region. These results 
correspond with previous studies that attributed this physician-nurse relationship 
to a hierarchical physician model that is prevalent in Italy. The disparity in attitudes 
between nurses and general practitioners raise concerns about the current devel-
opment of PCMHs and calls for further examination into the activities needed to 
change practice culture.
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objeCtives: The Risk Communication and Advisory Committee in 2009 recom-
mended that the Food and Drug Administration (FDA) adopt a standard single-page 
document to improve patient comprehension of prescription drug information. The 
objective of this study was to develop one-page prescription drug information leaf-
lets (PILs), and assess its impact on consumer comprehension across different levels 
of involvement. Methods: One-page PILs were developed using cognitive princi-
ples and graphics to exert lower mental effort. A 3x2 repeated measures experiment 
was conducted. Each participant was exposed to 3 types of leaflets specifically, the 
current practice (obtained from a community pharmacy), pre-existing one page 
text-only and PILs. Adults (≥ 18 years) in a university setting evaluated the leaflets 
after reading a scenario to simulate high and low involvement. A pre-validated, 
survey instrument was then used to measure information load, information anxi-
ety, product knowledge, attitude towards leaflet and intention to read. Results: 
Response rate of 61.96% was obtained (n= 360). Multivariate analysis of variance 
test indicated significant positive effect of leaflet type, involvement and interaction 
effect on all measured variables (Wilk’s lambda, p< 0.001). Individual analysis of vari-
ance tests on mean scores for leaflets followed by post-hoc Scheffe test revealed that 
PILs had the lowest scores on information load and information anxiety (p< 0.001). 
The product knowledge, attitude towards leaflet and intention to read scores were 
objeCtives: Access to sexual reproductive health information is a right and a 
means to survival, development and protection. It provides opportunity for the 
youth to be informed, empowered and educated, thus, enhancing their ability to 
make informed decisions and choices on sexual reproductive health related mat-
ters. The objective of this study was to investigate sources of sexual reproductive 
health rights information accessible to the youth. Methods: Household baseline 
survey was carried out in June 2012 where 10 sub locations randomly selected 
were surveyed. A structured questionnaire was used to collect reproductive health 
rights information from 1347 youths between 12-23 years in the households of 
whom 53% were females. Consent to administer the tool to the minors was sought 
from the parents and guardians. Statistical Package for Social Scientist (SPSS) 
computer program was used to analyze data. Results: The study showed that 
28% (377/1347) of the youth received sexual reproductive health right information 
from youth support (peer) groups; however, only 2% (27/1347) belonged to youth 
support groups. Thirty two percent (431/1347) received the information in audio 
form e.g. TVor Radio, 30% (404/1347) by talking amongst themselves and 9.8% 
(132/1347) from group discussions. Only 0.2 % (3/1347) received information from 
a health facility. ConClusions: There is sufficient evidence from other related 
surveys that a significant proportion of the youth engage in sexual activities while 
in their tender years unaware of the risks involved. The study recommends that 
there is need to make sexual reproductive health information readily accessible 
in the health facilities, schools, and colleges, universities, churches, mosques and 
youth support groups and in youth friendly formats that can be easily read and 
understood by all the youth. This will enhance their ability to make informed 
decisions and choices on sexual reproductive health related matters.
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objeCtives: Information on the availability and accessibility of administrative 
databases in Asia for health research is not widely understood. This study describes 
a qualitative comparison of administrative databases in Asia for health research by 
availability and accessibility. Methods: A search was conducted on Pubmed, Ovid, 
Google Scholar, the ISPOR International Digest of Databases and internet search 
engines to obtain information on the availability, type of information and accessibil-
ity of administrative databases for health research in Asia. The search was carried 
out to obtain information on different types of databases such as hospital records, 
reimbursement databases, prescription databases, case-mix databases and data 
linkages where available. Countries selected for this qualitative comparison was 
China, South Korea, Taiwan, Australia, Japan, Singapore, Malaysia and Thailand. 
In addition, contact was initiated with the database owners wherever possible to 
obtain more information on the databases. Results were tabulated based on the 
databases available by country, ease of access (high, medium, low, none), chal-
lenges for each type of database and type of information available within each 
database. Results: From the countries surveyed, Australia and Japan had the most 
number of databases available and accessible for health research. Databases are 
available and accessible in Taiwan and South Korea with certain limitations and 
restrictions. In China, Thailand, Singapore and Malaysia, there are limited numbers 
of databases available, however their accessibility for health research by private and 
public entities is not described. Some databases contained cost information while 
others did not. ConClusions: Administrative databases for health research are 
available, accessible and regularly utilised in several countries in Asia while data-
bases in other countries are not well established or readily available for research. 
The information from this study will help researchers plan their health research 
studies in Asia.
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objeCtives: The Brazilian Health Surveillance Agency (Anvisa) approved in 
October 2006 a specific legislation, the Resolution RDC 185/2006, which obliges 
the suppliers of medical devices to send economic information of their prod-
ucts to Anvisa. In order to reduce the information asymmetry in this market, 
the Economic Regulation Office (NUREM/ANVISA) has developed the database of 
economic information of medical devices and has published on Anvisa’s website 
a list of prices of some cardiologic and orthopedic devices. The list compares 
the supplier economic information to the data provided by different sources, 
such as specific medical devices journals, marketing authorization and research 
on international and Brazilian market. The aim of this study is to present an 
assessment of economic information of medical devices based on the ANVISA 
database. Methods: The data of medical devices were collected from Anvisa’s 
database of economic information from 2007 to 2013. The price from different 
regions (Brazilian, American and European) and the classes of medical devices 
(cardiologic and orthopedic devices) were compared. Results: The prices in 
Brazil are far superior to American and European countries. In 2013, consider-
ing different regions of Brazil, the prices can vary about 15%; the most expen-
sive cardiologic product identified was Implantable Cardioverter/Defibrillator, 
whilst the most expensive orthopedic one was the Intervertebral Prosthesis 
(Cage). ConClusions: These analyses allow the health care professionals 
and payers know the medical device pricing behavior regarding to the internal 
and international market. In summary, the free access of economic data of 
medical devices can increase the transparency, which can be helpful to support 
decisions of different stakeholders, who can distribute health care resources more 
efficiently in order to improve the health care conditions and to develop health 
public policies.
